

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.69835190 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.17826285 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.88098848 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.88098848 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.75068434 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.75068434 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.58201449 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.18196884 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17711749 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.58530524 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.58530524 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.58530524 |
| 13 | cysteine metabolic process (GO:0006534) | 5.48801328 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.47666005 |
| 15 | ethanol metabolic process (GO:0006067) | 5.42996838 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.42576145 |
| 17 | urea cycle (GO:0000050) | 5.41502563 |
| 18 | urea metabolic process (GO:0019627) | 5.41502563 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.36168568 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.35590476 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.28497021 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.26089467 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21142597 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.00877106 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.94744383 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.91639628 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.87975285 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85897092 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.80230775 |
| 30 | protein carboxylation (GO:0018214) | 4.80230775 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.77052571 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.75855112 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.74039770 |
| 34 | lysine metabolic process (GO:0006553) | 4.73342488 |
| 35 | lysine catabolic process (GO:0006554) | 4.73342488 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.70314273 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.66106229 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.65226015 |
| 39 | NADH metabolic process (GO:0006734) | 4.60400351 |
| 40 | bile acid metabolic process (GO:0008206) | 4.58929671 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.56416399 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56416399 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.56416399 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.54973192 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.53162764 |
| 46 | regulation of complement activation (GO:0030449) | 4.47336021 |
| 47 | phospholipid efflux (GO:0033700) | 4.46318181 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.41737853 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.41737853 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.40443309 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.40443309 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.35942562 |
| 53 | oxidative demethylation (GO:0070989) | 4.34578247 |
| 54 | glycine metabolic process (GO:0006544) | 4.26886167 |
| 55 | protein activation cascade (GO:0072376) | 4.22171189 |
| 56 | tyrosine metabolic process (GO:0006570) | 4.20342808 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.18796684 |
| 58 | complement activation, classical pathway (GO:0006958) | 4.18754866 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.18646036 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.15040552 |
| 61 | ethanol oxidation (GO:0006069) | 4.14428727 |
| 62 | complement activation (GO:0006956) | 4.13397450 |
| 63 | regulation of plasminogen activation (GO:0010755) | 4.12692594 |
| 64 | cellular glucuronidation (GO:0052695) | 4.12653926 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.10176538 |
| 66 | phenylpropanoid metabolic process (GO:0009698) | 4.08158434 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 4.06317329 |
| 68 | drug catabolic process (GO:0042737) | 4.03698904 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.03692092 |
| 70 | serine family amino acid biosynthetic process (GO:0009070) | 4.02660356 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.01590969 |
| 72 | cholesterol efflux (GO:0033344) | 4.00881564 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.99928541 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.96336794 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.94359407 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.94359407 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.92038405 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.89739191 |
| 79 | glutamate metabolic process (GO:0006536) | 3.89631321 |
| 80 | negative regulation of protein activation cascade (GO:2000258) | 3.86928241 |
| 81 | response to mercury ion (GO:0046689) | 3.85385233 |
| 82 | hormone catabolic process (GO:0042447) | 3.85014841 |
| 83 | amine catabolic process (GO:0009310) | 3.84580324 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.84580324 |
| 85 | negative regulation of blood coagulation (GO:0030195) | 3.84071424 |
| 86 | negative regulation of hemostasis (GO:1900047) | 3.84071424 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 3.82755969 |
| 88 | oxaloacetate metabolic process (GO:0006107) | 3.80451243 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.79358895 |
| 90 | flavonoid metabolic process (GO:0009812) | 3.78287128 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.76566168 |
| 92 | arginine metabolic process (GO:0006525) | 3.76415919 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74120166 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.72566491 |
| 95 | acute-phase response (GO:0006953) | 3.68922529 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.68163865 |
| 97 | sterol homeostasis (GO:0055092) | 3.67554275 |
| 98 | organic acid catabolic process (GO:0016054) | 3.67429969 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.67429969 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.67389679 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.66549965 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.66549965 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64325255 |
| 104 | drug transmembrane transport (GO:0006855) | 3.61825268 |
| 105 | protein-lipid complex assembly (GO:0065005) | 3.60387493 |
| 106 | fructose metabolic process (GO:0006000) | 3.59699416 |
| 107 | ketone body metabolic process (GO:1902224) | 3.58410141 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58238553 |
| 109 | urate metabolic process (GO:0046415) | 3.57725008 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.57490562 |
| 111 | primary alcohol catabolic process (GO:0034310) | 3.57476894 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.57320309 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 3.56869333 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.55873852 |
| 115 | valine metabolic process (GO:0006573) | 3.55734330 |
| 116 | negative regulation of coagulation (GO:0050819) | 3.54820970 |
| 117 | fatty acid oxidation (GO:0019395) | 3.54279574 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52258498 |
| 119 | lipoprotein metabolic process (GO:0042157) | 3.52130111 |
| 120 | drug metabolic process (GO:0017144) | 3.51172779 |
| 121 | phospholipid homeostasis (GO:0055091) | 3.50930337 |
| 122 | fibrinolysis (GO:0042730) | 3.50845453 |
| 123 | regulation of humoral immune response (GO:0002920) | 3.50839801 |
| 124 | negative regulation of wound healing (GO:0061045) | 3.43615497 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.38017672 |
| 126 | negative regulation of complement activation (GO:0045916) | 3.36982600 |
| 127 | alkaloid metabolic process (GO:0009820) | 3.35928569 |
| 128 | proline metabolic process (GO:0006560) | 3.32897621 |
| 129 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.31595996 |
| 130 | primary alcohol metabolic process (GO:0034308) | 3.25613363 |
| 131 | intestinal absorption (GO:0050892) | 3.24325885 |
| 132 | carnitine metabolic process (GO:0009437) | 3.19418139 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 3.14310188 |
| 134 | S-adenosylmethionine metabolic process (GO:0046500) | 3.13133782 |
| 135 | opsonization (GO:0008228) | 3.12347498 |
| 136 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.09959173 |
| 137 | polyketide metabolic process (GO:0030638) | 3.09948266 |
| 138 | doxorubicin metabolic process (GO:0044598) | 3.09948266 |
| 139 | daunorubicin metabolic process (GO:0044597) | 3.09948266 |
| 140 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.09365870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85289157 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.87061149 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.39617490 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98491374 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70331803 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85141606 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.70595551 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80656774 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.51271687 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.40022111 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47667918 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44669573 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1508117 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95721356 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94167958 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90119559 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80731377 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77661084 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66889493 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58878804 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49902696 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43654907 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40392332 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37943616 |
| 25 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35712467 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35298032 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27632895 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25320257 |
| 29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18621530 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17173576 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16970270 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11553191 |
| 33 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11525865 |
| 34 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11525865 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08153251 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06643681 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05554855 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03341008 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02631420 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01318544 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00310254 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98425453 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98014286 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95853962 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95540324 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94780354 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92845335 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92354998 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91315313 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91110390 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90854372 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89155582 |
| 53 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87059328 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86932745 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86843643 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86525621 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86023140 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85973729 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85139530 |
| 60 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82742628 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81929498 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80529712 |
| 63 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79611845 |
| 64 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79017891 |
| 65 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78061138 |
| 66 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76172299 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75143237 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74676253 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74091050 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72952159 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72809283 |
| 72 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72730396 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.72454290 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.72297937 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71921959 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71904464 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71213344 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70885624 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70860555 |
| 80 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70368247 |
| 81 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.69453611 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68315591 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68244055 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67534736 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67358338 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65509810 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64701622 |
| 88 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64543681 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64408976 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63665538 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.63609123 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62800232 |
| 93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62763157 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62525160 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62443703 |
| 96 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.62106094 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.61922220 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.61584373 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61552272 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61481819 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61481819 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61431498 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60924492 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60610415 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59749081 |
| 106 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.58448861 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58060356 |
| 108 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.58008059 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57928879 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.57701107 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.55097208 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54876783 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.53716240 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53594768 |
| 115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52641015 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52595689 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52068348 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52047662 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51596214 |
| 120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50772648 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.50432323 |
| 122 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50175198 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.49469924 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48796677 |
| 125 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47728488 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47260808 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47092730 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.46866899 |
| 129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46724052 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46607696 |
| 131 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46251691 |
| 132 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.45421258 |
| 133 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45323851 |
| 134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.45303965 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45239591 |
| 136 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.44866895 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.44516975 |
| 138 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44355037 |
| 139 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.43951667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.71455860 |
| 2 | MP0005360_urolithiasis | 7.57060169 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.83275411 |
| 4 | MP0005365_abnormal_bile_salt | 5.70463910 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73513246 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.98780442 |
| 7 | MP0003252_abnormal_bile_duct | 3.66140419 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.46833058 |
| 9 | MP0009840_abnormal_foam_cell | 3.30209766 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.90465536 |
| 11 | MP0005332_abnormal_amino_acid | 2.83101244 |
| 12 | MP0005083_abnormal_biliary_tract | 2.70849147 |
| 13 | MP0003195_calcinosis | 2.53767336 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.39111961 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.33035109 |
| 16 | MP0000609_abnormal_liver_physiology | 2.11962636 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.03051338 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.02990711 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.83197622 |
| 20 | MP0003868_abnormal_feces_composition | 1.77746128 |
| 21 | MP0001764_abnormal_homeostasis | 1.75602773 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.56882381 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56602385 |
| 24 | MP0003186_abnormal_redox_activity | 1.55294231 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.36806008 |
| 26 | MP0009697_abnormal_copulation | 1.33403344 |
| 27 | MP0003011_delayed_dark_adaptation | 1.30824563 |
| 28 | MP0005451_abnormal_body_composition | 1.28659035 |
| 29 | MP0000751_myopathy | 1.28484525 |
| 30 | MP0002254_reproductive_system_inflammat | 1.24371301 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.22249832 |
| 32 | MP0000598_abnormal_liver_morphology | 1.18482682 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.17762326 |
| 34 | MP0009764_decreased_sensitivity_to | 1.14116280 |
| 35 | MP0005670_abnormal_white_adipose | 1.10626504 |
| 36 | MP0000566_synostosis | 1.10559039 |
| 37 | MP0003879_abnormal_hair_cell | 1.09815390 |
| 38 | MP0005647_abnormal_sex_gland | 1.08090587 |
| 39 | MP0006138_congestive_heart_failure | 1.04860464 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.01691291 |
| 41 | MP0002249_abnormal_larynx_morphology | 1.01214701 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.01024785 |
| 43 | MP0009763_increased_sensitivity_to | 1.00949470 |
| 44 | MP0005330_cardiomyopathy | 1.00121389 |
| 45 | MP0008469_abnormal_protein_level | 1.00032694 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 0.99670030 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.99272288 |
| 48 | MP0004036_abnormal_muscle_relaxation | 0.90426370 |
| 49 | MP0005187_abnormal_penis_morphology | 0.90312800 |
| 50 | MP0009642_abnormal_blood_homeostasis | 0.89517896 |
| 51 | MP0000678_abnormal_parathyroid_gland | 0.87668991 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.87429986 |
| 53 | MP0003183_abnormal_peptide_metabolism | 0.86936064 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.84692279 |
| 55 | MP0000604_amyloidosis | 0.83321271 |
| 56 | MP0004130_abnormal_muscle_cell | 0.83254934 |
| 57 | MP0002971_abnormal_brown_adipose | 0.82961221 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.82801830 |
| 59 | MP0004272_abnormal_basement_membrane | 0.82648373 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.82181972 |
| 61 | MP0001756_abnormal_urination | 0.82045476 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.82041777 |
| 63 | MP0003724_increased_susceptibility_to | 0.80673816 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.75951487 |
| 65 | MP0005334_abnormal_fat_pad | 0.75018704 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.74796031 |
| 67 | MP0005408_hypopigmentation | 0.73956328 |
| 68 | MP0004087_abnormal_muscle_fiber | 0.72281011 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.72118084 |
| 70 | MP0004084_abnormal_cardiac_muscle | 0.71429740 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 0.69492831 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.66565759 |
| 73 | MP0002972_abnormal_cardiac_muscle | 0.66340667 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 0.66206919 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.65578787 |
| 76 | MP0005266_abnormal_metabolism | 0.65304158 |
| 77 | MP0001661_extended_life_span | 0.64920394 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.64632516 |
| 79 | MP0001544_abnormal_cardiovascular_syste | 0.64632516 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.64118077 |
| 81 | MP0002168_other_aberrant_phenotype | 0.64012772 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.63925940 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.62163175 |
| 84 | MP0005535_abnormal_body_temperature | 0.60342638 |
| 85 | MP0005409_darkened_coat_color | 0.58764926 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.58652590 |
| 87 | MP0002796_impaired_skin_barrier | 0.58361219 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.58152122 |
| 89 | MP0005448_abnormal_energy_balance | 0.57935211 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.57330732 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.56748851 |
| 92 | MP0000747_muscle_weakness | 0.56612439 |
| 93 | MP0003436_decreased_susceptibility_to | 0.56297816 |
| 94 | MP0000749_muscle_degeneration | 0.55859070 |
| 95 | MP0005620_abnormal_muscle_contractility | 0.55800111 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.55275401 |
| 97 | MP0004043_abnormal_pH_regulation | 0.54998556 |
| 98 | MP0004147_increased_porphyrin_level | 0.54789691 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.52962775 |
| 100 | MP0002132_abnormal_respiratory_system | 0.52767840 |
| 101 | MP0000462_abnormal_digestive_system | 0.51675846 |
| 102 | MP0009115_abnormal_fat_cell | 0.51596986 |
| 103 | MP0003718_maternal_effect | 0.51426042 |
| 104 | MP0003329_amyloid_beta_deposits | 0.51364604 |
| 105 | MP0002269_muscular_atrophy | 0.51105655 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.50757745 |
| 107 | MP0010630_abnormal_cardiac_muscle | 0.50653634 |
| 108 | MP0001853_heart_inflammation | 0.50287957 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.49246878 |
| 110 | MP0005395_other_phenotype | 0.49160890 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.48747035 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.48414633 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.46641132 |
| 114 | MP0009053_abnormal_anal_canal | 0.46440987 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.46331395 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.46230039 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.45863317 |
| 118 | MP0008873_increased_physiological_sensi | 0.45678407 |
| 119 | MP0005166_decreased_susceptibility_to | 0.44157191 |
| 120 | MP0001881_abnormal_mammary_gland | 0.42448461 |
| 121 | MP0004858_abnormal_nervous_system | 0.42246086 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.42096526 |
| 123 | MP0002928_abnormal_bile_duct | 0.41809741 |
| 124 | MP0002970_abnormal_white_adipose | 0.41802774 |
| 125 | MP0003690_abnormal_glial_cell | 0.41575357 |
| 126 | MP0003953_abnormal_hormone_level | 0.41283010 |
| 127 | MP0009379_abnormal_foot_pigmentation | 0.40708954 |
| 128 | MP0003075_altered_response_to | 0.40099154 |
| 129 | MP0006082_CNS_inflammation | 0.38878682 |
| 130 | MP0002060_abnormal_skin_morphology | 0.38802828 |
| 131 | MP0000249_abnormal_blood_vessel | 0.38520434 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.38225426 |
| 133 | MP0000685_abnormal_immune_system | 0.36990607 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.36834949 |
| 135 | MP0009785_altered_susceptibility_to | 0.35311156 |
| 136 | MP0008872_abnormal_physiological_respon | 0.34861103 |
| 137 | MP0002135_abnormal_kidney_morphology | 0.34559365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.79547148 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.51389609 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.35085980 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.13438880 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.96074451 |
| 6 | Xanthomatosis (HP:0000991) | 5.90820513 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.62558964 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.99927398 |
| 9 | Complement deficiency (HP:0004431) | 4.69000599 |
| 10 | Hyperammonemia (HP:0001987) | 4.68045878 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57180584 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.51883898 |
| 13 | Hyperglycinuria (HP:0003108) | 4.43515628 |
| 14 | Hyperglycinemia (HP:0002154) | 4.30581641 |
| 15 | Ketosis (HP:0001946) | 4.24621994 |
| 16 | Joint hemorrhage (HP:0005261) | 4.19687074 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.17484120 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17484120 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14052330 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.02372484 |
| 21 | Epidermoid cyst (HP:0200040) | 4.02273877 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.01150719 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.98236117 |
| 24 | Fat malabsorption (HP:0002630) | 3.94468560 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.92138385 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.91256183 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.75233350 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64367115 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58793554 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56624245 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48657029 |
| 32 | Abnormality of complement system (HP:0005339) | 3.44372847 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42827762 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.39904751 |
| 35 | Nephritis (HP:0000123) | 3.37812299 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.27289890 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26345365 |
| 38 | Ketoacidosis (HP:0001993) | 3.22095473 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.08645556 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.07334490 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.02427626 |
| 42 | Metabolic acidosis (HP:0001942) | 2.93475880 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.89296261 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89296261 |
| 45 | Steatorrhea (HP:0002570) | 2.87135456 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.79499995 |
| 47 | Lethargy (HP:0001254) | 2.79051560 |
| 48 | Gout (HP:0001997) | 2.76048517 |
| 49 | Myocardial infarction (HP:0001658) | 2.74992355 |
| 50 | Acanthocytosis (HP:0001927) | 2.72786971 |
| 51 | Malnutrition (HP:0004395) | 2.69221026 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.54896783 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.53142990 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.51508387 |
| 55 | Vascular calcification (HP:0004934) | 2.51326765 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.48878132 |
| 57 | Cerebral edema (HP:0002181) | 2.47761927 |
| 58 | Spontaneous abortion (HP:0005268) | 2.47610052 |
| 59 | Skin nodule (HP:0200036) | 2.46555974 |
| 60 | Spastic diplegia (HP:0001264) | 2.44645987 |
| 61 | Exercise-induced myalgia (HP:0003738) | 2.41468023 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.38596094 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.38596094 |
| 64 | Pancreatitis (HP:0001733) | 2.37428446 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.35880085 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.32743424 |
| 67 | Rhabdomyolysis (HP:0003201) | 2.28902895 |
| 68 | Abnormality of glycolysis (HP:0004366) | 2.28690058 |
| 69 | Osteomalacia (HP:0002749) | 2.28221730 |
| 70 | Irritability (HP:0000737) | 2.27826864 |
| 71 | Late onset (HP:0003584) | 2.27347945 |
| 72 | Vomiting (HP:0002013) | 2.26906896 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.23643275 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.21065065 |
| 75 | Atrioventricular block (HP:0001678) | 2.18597699 |
| 76 | Esophageal varix (HP:0002040) | 2.17571059 |
| 77 | Amyloidosis (HP:0011034) | 2.16671407 |
| 78 | Neonatal onset (HP:0003623) | 2.15713248 |
| 79 | Alkalosis (HP:0001948) | 2.13236153 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.13039486 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.12935227 |
| 82 | Cholelithiasis (HP:0001081) | 2.12585234 |
| 83 | Glomerulonephritis (HP:0000099) | 2.12400941 |
| 84 | Glycosuria (HP:0003076) | 2.11160612 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.11160612 |
| 86 | Gingival bleeding (HP:0000225) | 2.10871177 |
| 87 | Menorrhagia (HP:0000132) | 2.10756302 |
| 88 | Brushfield spots (HP:0001088) | 2.10089963 |
| 89 | Nausea (HP:0002018) | 2.09470011 |
| 90 | Myoglobinuria (HP:0002913) | 2.08576531 |
| 91 | Abnormal cartilage morphology (HP:0002763) | 2.07677457 |
| 92 | Poikilocytosis (HP:0004447) | 2.07664811 |
| 93 | Hyperuricemia (HP:0002149) | 2.06832074 |
| 94 | Increased purine levels (HP:0004368) | 2.06832074 |
| 95 | Hyperphosphaturia (HP:0003109) | 2.05629034 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05314338 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04882232 |
| 98 | Cholecystitis (HP:0001082) | 2.03089435 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.03089435 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.99648127 |
| 101 | Thrombophlebitis (HP:0004418) | 1.97340571 |
| 102 | Potter facies (HP:0002009) | 1.93810173 |
| 103 | Facial shape deformation (HP:0011334) | 1.93810173 |
| 104 | Opisthotonus (HP:0002179) | 1.93454282 |
| 105 | Mitral stenosis (HP:0001718) | 1.93400959 |
| 106 | Enlarged kidneys (HP:0000105) | 1.91419727 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.91187784 |
| 108 | Abnormal urine phosphate concentration (HP:0012599) | 1.89944351 |
| 109 | Hypertriglyceridemia (HP:0002155) | 1.89359056 |
| 110 | Muscle fiber inclusion bodies (HP:0100299) | 1.88736414 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87946183 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87129127 |
| 113 | Rickets (HP:0002748) | 1.86807840 |
| 114 | Nemaline bodies (HP:0003798) | 1.83936101 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.82627716 |
| 116 | Hypophosphatemia (HP:0002148) | 1.82276179 |
| 117 | Abnormality of the Achilles tendon (HP:0005109) | 1.81189158 |
| 118 | Megaloblastic anemia (HP:0001889) | 1.80621575 |
| 119 | Heart block (HP:0012722) | 1.79901497 |
| 120 | Abnormal atrioventricular conduction (HP:0005150) | 1.77845881 |
| 121 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76136422 |
| 122 | Neonatal hypoglycemia (HP:0001998) | 1.73536309 |
| 123 | Bifid scrotum (HP:0000048) | 1.72813961 |
| 124 | Pigmentary retinal degeneration (HP:0001146) | 1.72802013 |
| 125 | Nephrolithiasis (HP:0000787) | 1.72581209 |
| 126 | Cerebral palsy (HP:0100021) | 1.69875843 |
| 127 | Elevated alkaline phosphatase (HP:0003155) | 1.68861412 |
| 128 | Confusion (HP:0001289) | 1.66908300 |
| 129 | Widely patent fontanelles and sutures (HP:0004492) | 1.65694107 |
| 130 | Focal segmental glomerulosclerosis (HP:0000097) | 1.65634115 |
| 131 | Purpura (HP:0000979) | 1.64809174 |
| 132 | Type 1 muscle fiber predominance (HP:0003803) | 1.61445944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.78692788 |
| 2 | ERN1 | 4.77020171 |
| 3 | SIK1 | 3.89407126 |
| 4 | OBSCN | 3.64572872 |
| 5 | FGFR4 | 3.58355133 |
| 6 | TAOK3 | 2.66013357 |
| 7 | MST1R | 2.40075539 |
| 8 | TRIB3 | 2.39535687 |
| 9 | EPHA2 | 2.36000785 |
| 10 | PDK2 | 2.34845135 |
| 11 | EPHB2 | 2.27016857 |
| 12 | PKN2 | 2.24150506 |
| 13 | FLT3 | 2.21712637 |
| 14 | INSRR | 2.06385128 |
| 15 | TTN | 1.96584322 |
| 16 | FRK | 1.94558291 |
| 17 | DMPK | 1.92463726 |
| 18 | TYK2 | 1.80933607 |
| 19 | PIK3CG | 1.80350753 |
| 20 | MAPK11 | 1.78118798 |
| 21 | ERBB4 | 1.71173068 |
| 22 | KDR | 1.70463400 |
| 23 | PHKG1 | 1.58350408 |
| 24 | PHKG2 | 1.58350408 |
| 25 | IRAK3 | 1.53783372 |
| 26 | NME2 | 1.52277499 |
| 27 | GRK6 | 1.48860504 |
| 28 | PTK6 | 1.47719354 |
| 29 | NEK9 | 1.44487564 |
| 30 | TIE1 | 1.42465998 |
| 31 | LATS1 | 1.40285335 |
| 32 | TBK1 | 1.37106199 |
| 33 | PDGFRA | 1.33800940 |
| 34 | LATS2 | 1.31109034 |
| 35 | MAP3K11 | 1.23941453 |
| 36 | MAP3K10 | 1.22205735 |
| 37 | ABL2 | 1.21217689 |
| 38 | TESK1 | 1.18257696 |
| 39 | PRKAA2 | 1.18255891 |
| 40 | MAP2K3 | 1.18065107 |
| 41 | MAP2K4 | 1.16018888 |
| 42 | MUSK | 1.15064141 |
| 43 | MAP3K7 | 1.13063978 |
| 44 | MAP3K3 | 1.11399309 |
| 45 | JAK2 | 1.10913261 |
| 46 | TGFBR2 | 1.10094635 |
| 47 | PRPF4B | 1.05613175 |
| 48 | ICK | 1.00667538 |
| 49 | ARAF | 1.00015485 |
| 50 | STK39 | 0.97377169 |
| 51 | FER | 0.97026918 |
| 52 | KSR2 | 0.92084773 |
| 53 | MAP4K1 | 0.91232155 |
| 54 | NTRK1 | 0.91028361 |
| 55 | JAK1 | 0.90703667 |
| 56 | AKT2 | 0.90351973 |
| 57 | PINK1 | 0.88006468 |
| 58 | MAPK4 | 0.87917118 |
| 59 | RIPK1 | 0.87846238 |
| 60 | MAP3K14 | 0.87050313 |
| 61 | LMTK2 | 0.86674902 |
| 62 | SGK223 | 0.85914835 |
| 63 | SGK494 | 0.85914835 |
| 64 | MAP3K2 | 0.85019882 |
| 65 | MAP2K2 | 0.84244056 |
| 66 | MAP2K6 | 0.82756126 |
| 67 | MAPKAPK3 | 0.82675924 |
| 68 | MAPK15 | 0.81135952 |
| 69 | DYRK1B | 0.80721210 |
| 70 | AKT3 | 0.80377981 |
| 71 | SCYL2 | 0.77133649 |
| 72 | CAMK1D | 0.77049049 |
| 73 | IKBKE | 0.76767305 |
| 74 | EPHB1 | 0.76437345 |
| 75 | CDK6 | 0.75643167 |
| 76 | SGK2 | 0.74687079 |
| 77 | ERBB2 | 0.74059243 |
| 78 | CSF1R | 0.72748274 |
| 79 | PRKG2 | 0.71300625 |
| 80 | CSK | 0.71241079 |
| 81 | OXSR1 | 0.70336490 |
| 82 | LRRK2 | 0.70287615 |
| 83 | SGK3 | 0.70070274 |
| 84 | MAPK12 | 0.69884723 |
| 85 | RET | 0.69511351 |
| 86 | DDR2 | 0.68517580 |
| 87 | CAMK2D | 0.68327955 |
| 88 | CAMK2B | 0.67375907 |
| 89 | MET | 0.67044573 |
| 90 | STK24 | 0.66205489 |
| 91 | KIT | 0.65674307 |
| 92 | NLK | 0.65173607 |
| 93 | STK38L | 0.62989737 |
| 94 | GRK1 | 0.59026236 |
| 95 | CDK4 | 0.58419173 |
| 96 | GSK3A | 0.58412965 |
| 97 | PRKD3 | 0.57686347 |
| 98 | PRKAA1 | 0.57323639 |
| 99 | JAK3 | 0.56694906 |
| 100 | BRSK2 | 0.54651869 |
| 101 | ZAP70 | 0.53096244 |
| 102 | PRKG1 | 0.52475716 |
| 103 | DAPK2 | 0.51925899 |
| 104 | PRKACG | 0.50225568 |
| 105 | PRKACA | 0.50116539 |
| 106 | EPHA3 | 0.49683737 |
| 107 | ACVR1B | 0.49394664 |
| 108 | PIM2 | 0.46984298 |
| 109 | MYLK | 0.46717920 |
| 110 | PRKCZ | 0.46034256 |
| 111 | MAP3K6 | 0.45815305 |
| 112 | PAK4 | 0.44716536 |
| 113 | EIF2AK1 | 0.43635501 |
| 114 | PTK2 | 0.43399281 |
| 115 | RPS6KA3 | 0.42667893 |
| 116 | GRK5 | 0.42329211 |
| 117 | NEK6 | 0.41892709 |
| 118 | BLK | 0.41482927 |
| 119 | CAMK2G | 0.40910314 |
| 120 | STK16 | 0.40152469 |
| 121 | STK10 | 0.39730525 |
| 122 | MAP3K12 | 0.39502664 |
| 123 | PDK1 | 0.39245945 |
| 124 | MAP2K1 | 0.39007510 |
| 125 | LIMK1 | 0.38989988 |
| 126 | PDPK1 | 0.38976304 |
| 127 | PRKD1 | 0.38361023 |
| 128 | TEC | 0.37940606 |
| 129 | MTOR | 0.37311378 |
| 130 | NTRK3 | 0.36584156 |
| 131 | PDK3 | 0.36494983 |
| 132 | PDK4 | 0.36494983 |
| 133 | PBK | 0.36395028 |
| 134 | PIK3CA | 0.36256045 |
| 135 | BTK | 0.35953990 |
| 136 | MAP3K5 | 0.35922223 |
| 137 | SGK1 | 0.34079576 |
| 138 | MAP3K13 | 0.33674204 |
| 139 | FGFR3 | 0.33302148 |
| 140 | IGF1R | 0.32210722 |
| 141 | IRAK1 | 0.31987857 |
| 142 | WNK4 | 0.31526947 |
| 143 | MAPK7 | 0.30397955 |
| 144 | PRKCQ | 0.30050314 |
| 145 | PIM1 | 0.29581355 |
| 146 | MAP3K1 | 0.29260108 |
| 147 | NEK1 | 0.29217930 |
| 148 | EEF2K | 0.29161119 |
| 149 | MATK | 0.29131913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.06861719 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40738300 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38822850 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89428897 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86760179 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62113442 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60946833 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60454665 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50552670 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45868688 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43190406 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42496388 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42139666 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.10835270 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09183261 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06240138 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99515063 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96609585 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90109216 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89618104 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89397776 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87604519 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83827348 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77732443 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76162487 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75033188 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70032503 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68963020 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62283622 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59843367 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58553288 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55575839 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52034844 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51000853 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50942383 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45665248 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45651096 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44879982 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.44871854 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41692430 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39332630 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29885688 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26516344 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25725698 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25430852 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24643107 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23026515 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.22118956 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19827214 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.15310893 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09149573 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06923918 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06168918 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05708632 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98227883 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95345800 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91324092 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90928843 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83736390 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81472447 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80966273 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79659074 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78135038 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76180928 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.75758708 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64953638 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54463821 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54062356 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53765133 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49978074 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33694776 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25374312 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25098648 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22563789 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22462377 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19539834 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16274114 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.15453981 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.14331792 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11518265 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07951697 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04334946 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03361969 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02227247 |
| 85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.01812527 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.00450822 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00153801 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1760591 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1750971 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1737862 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1731185 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1707148 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1639178 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | -0.1568539 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1442402 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1282060 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1260466 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0882347 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.0862110 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0638986 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0595820 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0554406 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0524572 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | -0.0402107 |
| 105 | Tight junction_Homo sapiens_hsa04530 | -0.0371318 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0361380 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0357649 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0332918 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0205168 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0150293 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0125963 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0119859 |
| 113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0099622 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | -0.0057934 |

